On Dec 15, Medicilon held Client AppreciationDinners in Boston. Medicilon CEO, Dr. Chunlin Chen, welcomed the friends and peers from Boston pharmaceutical community to join
The “Cooperation Advantage and Innovative Technology of CRO’s New Drug Development Forum” was held in Nanjing BSK Community on December 5. The CEO of Medicilon,
The “UK-China Partners for Growth and Innovation in Biopharmaceuticals Forum & Partnership Workshop” was held on November 25. The workshop was co-hosted by British Consulate
Medicilon recently purchased a Biological Research Irradiator from Rad Source, a US company which specialized in irradiators. This new purchase will enable Medicilon to expand
Shanghai Medicilon Inc.